BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9473545)

  • 1. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience.
    Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M
    Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
    Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
    Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasolacrimal polyurethane stent: complications with CT correlation.
    Pinto IT; Paul L; Grande C
    Cardiovasc Intervent Radiol; 1998; 21(6):450-3. PubMed ID: 9853160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
    Schaudig U; Maas R
    Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal polyurethane stent placement: preliminary results.
    Perena MF; Castillo J; Medrano J; De Gregorio MA; Loras E; Cristobal JA
    Eur J Ophthalmol; 2001; 11(1):25-30. PubMed ID: 11284481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nasolacrimal duct obstruction with polyurethane stent placement: long-term results.
    Yazici Z; Yazici B; Parlak M; Tuncel E; Ertürk H
    AJR Am J Roentgenol; 2002 Aug; 179(2):491-4. PubMed ID: 12130461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing?
    Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsurgical placement of a nasolacrimal polyurethane stent.
    Song HY; Jin YH; Kim JH; Huh SJ; Kim YH; Kim TH; Sung KB
    Radiology; 1995 Jan; 194(1):233-7. PubMed ID: 7997560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
    Lee JH; Kang MS; Yang JW
    Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
    Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
    Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents.
    Song HY; Jin YH; Kim JH; Sung KB; Han YM; Cho NC
    Radiology; 1994 Feb; 190(2):535-9. PubMed ID: 8284412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents: preliminary results.
    Paúl L; Pinto I; Vicente JM
    Clin Radiol; 2003 Nov; 58(11):876-82. PubMed ID: 14581012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of polyurethane stent implantation for the treatment of complete obstruction of the nasolacrimal system: 8-month follow-up and complications].
    Anders N; Hoffmann KT; Hosten N; Walkow T; Felix R; Hartmann C
    Ophthalmologe; 1999 Oct; 96(10):658-62. PubMed ID: 10552159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct].
    Posthuma BJ; van Imhoff WL; van Wezer JE
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study.
    Lanciego C; De Miguel S; Perea M; Cano C; García IR; Dávila J; Ibarburen C; Toledano N; Rodriguez-Merlo R; García LG
    J Vasc Interv Radiol; 2001 Jun; 12(6):701-10. PubMed ID: 11389221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nasolacrimal stent implantation: report of a case].
    Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of epiphora with nasolacrimal stents: results of long-term follow-up in a multicenter prospective study.
    Lanciego C; Toledano N; De Miguel S; Perea M; Padilla M; Rodriguez-Merlo R; Dávila J; Ibarburen C; Cano C; García IR; García LG
    J Vasc Interv Radiol; 2003 Nov; 14(11):1417-25. PubMed ID: 14605107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasolacrimal stents for the treatment of epiphora: technical problems and long-term results.
    Pinilla I; Fernández-Prieto AF; Asencio M; Arbizu A; Peláez N; Frutos R
    Orbit; 2006 Jun; 25(2):75-81. PubMed ID: 16754213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lacrimal stenoses obstructions with interventional radiology: immediate and 5-year follow-up results.
    Preziosi P; Di Primio M; Erdembileg T; Mancino R; D'Este G; Cerulli L; Simonetti G
    Radiol Med; 2008 Dec; 113(8):1211-8. PubMed ID: 18784907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.